Guangxi Medical University

• NCT05898256

  Phase 1/2, Status unknown, 20 people, 12 Jun 2023

• NCT05711823

  Phase 3, Status unknown, 300 people, 3 Feb 2023

• NCT05697185

  Phase 4, Status unknown, 200 people, 25 Jan 2023

• NCT04229355

  Phase 3, Status unknown, 90 people, 18 Jan 2020

• NCT04163237

  Phase 3, Status unknown, 50 people, 14 Nov 2019

• NCT04129710

  Collaborator, Phase 2, Status unknown, 120 people, 17 Oct 2019

• NCT03971201

  Collaborator, Phase 2, Status unknown, 200 people, 3 Jun 2019

• NCT03184493

  Phase 3, Status unknown, 200 people, 12 Jun 2017

• NCT03161574

  Phase 2, Withdrawn, 0 people, 22 May 2017

• NCT02585479

  Phase 2/3, Withdrawn, 0 people, 23 Oct 2015

• NCT02534337

  Phase 2/3, Withdrawn, 0 people, 27 Aug 2015

• NCT02527772

  Phase 2/3, Withdrawn, 0 people, 19 Aug 2015

• NCT02436902

  Phase 3, Status unknown, 240 people, 7 May 2015

• NCT02116231

  Phase 2, Status unknown, 80 people, 16 Apr 2014

• NCT02115152

  Phase 2, Status unknown, 100 people, 15 Apr 2014

• NCT01872962

  Collaborator, Phase 3, Status unknown, 480 people, 7 Jun 2013

• NCT01616849

  Collaborator, Phase 2, Completed, 39 people, 12 Jun 2012

• NCT01479504

  Phase 3, Status unknown, 2 people, 24 Nov 2011

• Chronic sleep deprivation induces ovarian ferroptosis and premature ovarian insufficiency linked to IL-17 signaling

  2 Sept 2026

• Escitalopram accelerated aging via impaired IIS/autophagy signaling pathway

  2024GXNSFAA010443, 5 Mar 2026

• Resistance training for the prevention and management of sarcopenia in older adults: Mechanisms, efficacy, and future applications

  YYZS2022010, 3 Mar 2026

Sources: api.crossref.org